Drug & intervention
methylene blue
RxCUI 6878
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
9 shownA French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.NCT06024213 · 2023-06-06
COMPLETEDThe Effect of Combination Therapy of Oral MB and PRP-FG in Patients With Non-healing Diabetic Foot UlcerNCT05850611 · 2023-04-30
UNKNOWNMethylene Blue for the Prevention of Hypotension During HemodialysisNCT05092165 · 2021-10-21
COMPLETED3D Printing for Nodule LocalizationNCT04056923 · 2018-01-01
COMPLETEDSentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICGNCT03579979 · 2017-08-24
COMPLETEDEffects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's DiseaseNCT02380573 · 2015-07-01
COMPLETEDApplication of Surgical Navigation System in Sentinel Lymph Node of Breast Cancer ResearchNCT02084784 · 2014-01-01
COMPLETEDSentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.NCT01276054 · 2010-12-01
TERMINATEDFeasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)NCT00784849 · 2004-11-01
COMPLETEDConditions being studied
Breast Cancer4Sentinel Lymph Node2Acute Kidney Injury1AD1Aging1Alzheimer's Disease1Diabetic Foot Ulcers1Diabetic Wound1Intradialytic Hypertension in Hemodialysis Patients1Intradialytic Hypotension1Lung Cancer1Lymphedema1MCI1Mild Cognitive Impairment1Pulmonary Nodule, Solitary1Recurrent Breast Cancer1Shock1Stage IA Breast Cancer1Stage IB Breast Cancer1Stage II Breast Cancer1
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.